Kura Oncology (KURA) Interest & Investment Income (2015 - 2026)
Kura Oncology (KURA) reported Interest & Investment Income of $5.8 million for Q1 2026, down 26.06% year-over-year from $7.9 million in Q1 2025, and down 26.06% quarter-over-quarter from $7.9 million in Q1 2025.
Kura Oncology (KURA) Interest & Investment Income (2015 - 2026) Analysis & Trends
Kura Oncology (KURA) has 12 years of Interest & Investment Income data on file, last reported at $5.8 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $5.8 million, down 26.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.3 million (down 0.58% YoY), and the FY2025 annual result was $26.8 million, up 17.18% from the prior year.
- Interest & Investment Income retreated to $5.8 million in Q1 2026 per KURA's latest filing, from $7.9 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $7.9 million in Q1 2025 and troughed at $329000.0 in Q1 2022.
- A 5-year average of $4.0 million and a median of $4.3 million in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2026: Interest & Investment Income jumped 769.6% in 2023, then decreased 26.06% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $2.3 million in 2022, then surged by 92.43% to $4.4 million in 2023, then rose by 29.5% to $5.7 million in 2024, then surged by 39.23% to $7.9 million in 2025, then declined by 26.06% to $5.8 million in 2026.
- Business Quant data shows KURA's Interest & Investment Income at $5.8 million in Q1 2026, $7.9 million in Q1 2025, and $5.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | 5.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.83 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | 5.66 Mn |
| Sep 30, 2024 | 5.89 Mn |
| Jun 30, 2024 | 5.97 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 2.86 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 564,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 311,000.00 |
| Jun 30, 2021 | 290,000.00 |
| Mar 31, 2021 | 310,000.00 |
| Dec 31, 2020 | 317,000.00 |
| Sep 30, 2020 | 571,000.00 |